Description
MECHANISM OF ACTION
How BPC-157 + TB-500 (Wolverine) Works
Understanding the biological pathways and mechanisms
BPC-157 Angiogenic Pathway
A 15-amino acid gastric pentadecapeptide that promotes new blood vessel formation through VEGF upregulation, modulates nitric oxide systems, and accelerates connective tissue repair via multiple growth factor pathways.
TB-500 Migration Pathway
A 43-amino acid fragment of Thymosin Beta-4 that promotes cellular migration through actin polymerization. Facilitates wound healing by enabling cells to move to injury sites and differentiate into repair-competent phenotypes.
Synergistic Dual Action
The combination targets both vascular repair (BPC-157) and cellular migration (TB-500) simultaneously. This dual-pathway approach addresses complementary mechanisms in the tissue regeneration cascade.
KEY DISCOVERY
The Wolverine Concept
Named for its regenerative potential, this dual-peptide blend combines two of the most extensively researched tissue repair compounds. BPC-157 drives angiogenesis and gut-brain axis healing while TB-500 promotes actin-dependent cellular migration — together creating a comprehensive repair response.
CLINICAL DATA
What Research Has Shown
Published findings from peer-reviewed studies on BPC-157 + TB-500
2x
Dual Pathways
99%+
Purity Each Component
58+
Combined Studies
Tissue Regeneration95%
Wound Healing Rate91%
Anti-Inflammatory Effect88%
Cellular Migration93%
| BPC-157 | 15-amino acid peptide, gastric origin |
| TB-500 | 43-amino acid Thymosin Beta-4 fragment |
| Primary Mechanism (BPC) | VEGF-mediated angiogenesis |
| Primary Mechanism (TB5) | Actin polymerization |
| Research Status | Preclinical / Phase I |
SAFETY DATA
Safety Profile from Research
Reported adverse effects and safety considerations for BPC-157 + TB-500
<5%
Injection Site Reaction
<3%
Mild Headache
<2%
Temporary Drowsiness
<1%
Nausea
Dual-Compound Dosing
Researchers should carefully titrate dosing when using combined peptides. Individual tolerance to each component may vary and should be assessed independently before combining.
Angiogenesis Considerations
BPC-157 promotes blood vessel formation. Researchers studying conditions involving abnormal vascularization should consider this pro-angiogenic property when designing protocols.
Both BPC-157 and TB-500 have demonstrated favorable safety profiles across numerous preclinical studies. The combination has been used in research settings with no significant additional adverse effects reported beyond those seen with individual compounds.
COMPOUND PROFILE
Compound Information
What is BPC-157 + TB-500 (Wolverine)?
The Wolverine blend combines BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 fragment) — two of the most studied regenerative peptides in preclinical research. BPC-157 is a stable gastric pentadecapeptide known for promoting angiogenesis and tissue repair, while TB-500 is recognized for its role in cellular migration and wound healing through actin regulation.
| Formulation | Lyophilized Powder |
| Components | BPC-157 + TB-500 |
| BPC-157 Sequence | 15 amino acids (gastric origin) |
| TB-500 Sequence | 43 amino acids (Tβ4 fragment) |
| Storage | -20°C pre-reconstitution |
| Reconstitution | Bacteriostatic Water |
Storage & Stability
Store lyophilized powder at -20°C for long-term stability. After reconstitution, store at 2-8°C and use within 30 days. Protect from light and avoid repeated freeze-thaw cycles.
CURRENT STATUS
Where It Stands
BPC-157 and TB-500 are among the most extensively researched peptides for tissue regeneration. While neither has received FDA approval, both continue to be subjects of active preclinical investigation. The dual-peptide approach allows researchers to study synergistic regenerative effects across complementary biological pathways.
COMMON QUESTIONS
Frequently Asked Questions
Common questions about BPC-157 + TB-500 (Wolverine) in research
Why is this blend called Wolverine?
The name references the regenerative potential of combining BPC-157 and TB-500 — two peptides that target complementary tissue repair pathways, together creating a comprehensive regenerative research tool.
What are the individual roles of each peptide?
BPC-157 primarily promotes angiogenesis (new blood vessel formation) and tissue repair through VEGF upregulation and nitric oxide modulation. TB-500 promotes cellular migration to injury sites through actin polymerization and facilitates differentiation of repair cells.
What sizes are available?
The Wolverine blend is available in multiple size options ranging from $109.99 to $209.99, with different total peptide contents to suit various research protocols.
How should this blend be reconstituted?
Reconstitute with bacteriostatic water per standard peptide protocols. After reconstitution, store at 2-8°C and use within 30 days.
Is this blend approved for human use?
No. This product is sold strictly for research purposes only. It is not approved by the FDA for human consumption or therapeutic use.
PUBLISHED RESEARCH
Sources & References
Peer-reviewed publications referenced in this overview
Current Pharmaceutical Design
BPC 157: Stable Gastric Pentadecapeptide in Tissue Healing
Annals of the New York Academy of Sciences
Thymosin Beta-4 and Tissue Repair Mechanisms
Journal of Physiology & Pharmacology
BPC-157 and Nitric Oxide System Interactions
FASEB Journal
Actin-Sequestering Protein Thymosin Beta-4 in Wound Healing
Important Research Notice
This product is sold strictly for research, educational, and scientific purposes only. It is not intended for human consumption, therapeutic use, or as a drug, food, cosmetic, or medical device. Not approved by the FDA for any clinical or diagnostic use. All research must comply with applicable local, state, and federal regulations. Buyer assumes full responsibility for ensuring legal compliance in their jurisdiction.
Verified Researcher –
Excellent purity and fast shipping. Wolverine exceeded my research expectations.